NRG Oncology trial results show no survival benefit with the use of proton therapy for patients with advanced hepatocellular carcinoma
Share proton therapy across national borders and plan five new centres in Romania, Greece, Italy, Northern Ireland and Poland to maximise access for patients in Europe - EurekAlert!
Proton therapy shows survival benefit in Phase III trial for patients with head and neck cancers - EurekAlert!
NRG Oncology trial analysis shows improvement in survival outcomes for glioblastoma patients receiving proton therapy, trial moves to phase III - EurekAlert!
Intensity-modulated radiation therapy (IMRT) matches proton therapy in patient-reported outcomes for oropharyngeal cancer - EurekAlert!
Proton therapy demonstrates advantages in Phase III head and neck cancer trial
ASCO: Proton therapy demonstrates advantages in Phase III head and neck cancer trial - EurekAlert
